Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.
Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2004 Financial Results Ann Arbor, Michigan, April 29, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM), today reported financial results for the third quarter of fiscal year 2004 ended March 31, 2004.
Aastrom Biosciences' CEO to Present at Rodman & Renshaw Techvest Global Healthcare Conference Ann Arbor, Michigan, May 6, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that R. Douglas Armstrong, Ph.D., Chairman, President and Chief Executive Officer, will present at the Rodman
Aastrom Biosciences Appoints James A. Cour as President and COO Ann Arbor, Michigan, July 6, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today the appointment of James A. Cour as President and Chief Operating Officer. Mr. Cour will be responsible for the day-to-day operations of
Aastrom Biosciences to Hold Investor Conference Call Tomorrow Ann Arbor, Michigan, September 7, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that it will hold an investor conference call tomorrow, Wednesday, September 8, 2004 at 11:00 a.m. (EDT).
Aastrom Biosciences to Hold Investor Conference Call Ann Arbor, Michigan, September 7, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that it will hold an investor conference call on Wednesday, September 8, 2004 at 11:00 a.m. (EDT).
Aastrom Biosciences, Inc. Reports Fourth Quarter 2004 Financial Results Ann Arbor, Michigan, September 8, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today reported financial results for the fourth quarter and fiscal year ended June 30, 2004. The Company also reported significant
Aastrom Biosciences' CEO to Present at Roth Capital Partners New York Conference Ann Arbor, Michigan, September 9, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that R. Douglas Armstrong, Ph.D., Chief Executive Officer and Chairman, will present at the Roth Capital Partners New
Aastrom Biosciences Announces Appointment of Janet M. Hock, B.D.S., Ph.D. As Vice President Global Research Ann Arbor, Michigan, September 14, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced the appointment of Janet M. Hock, B.D.S., Ph.D. as Vice President Global Research. Dr.
